Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

What’s Going On With ContraFecta Stock Today

ContraFect Corporation (NASDAQ: CFRX) shares are trading higher Thursday morning. However, there is no specific news to justify the move.
byVandana Singh
April 27, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • ContraFect Corporation (NASDAQ:CFRX) shares are trading higher Thursday morning. However, there is no specific news to justify the move.
  • Wednesday morning, ContraFect announced the dosing of the first patient in Phase 1b/2 of exebacase in the setting of an arthroscopic debridement, antibiotics, irrigation, and retention procedure in patients with chronic prosthetic joint infections of the knee due to Staphylococcus aureus or Coagulase-Negative Staphylococci.
  • The study was initiated earlier this month.
  • ContraFect stock is gaining on heavy volume, with a session volume of 55 million shares traded, compared to the trailing 100-day volume of 3.08 million shares.
  • According to data from Benzinga Pro, CFRX has a 52-week high of $362.4 and a 52-week low of $0.90.
  • Price Action: CFRX shares are up 68.20% at $2.22 on the last check Thursday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Canopy Growth Announces Financing Deal Including Roughly $50M Of New Gross Proceeds

By Jelena Martinovic
May 3, 9:31 AM
Canopy Growth Corporation has entered into an exchange and subscription agreement with a single institutional investor under which the Smiths Falls, Ontario-based company is expected to receive gross proceeds of roughly $50 million and exchange approximately CA$27.5 million ($20 million) of existing debt maturing in September 2025 for a new senior unsecured convertible debenture of the company maturing five years following the day of issuance. Under the terms of the deal, the investor will acquire a convertible debenture in an aggregate principal amount equal to CA$96,358,375 on closing.

CGC